Cargando…

Who and what influences delayed presentation in breast cancer?

This study aimed to examine the extent and determinants of patient and general practitioner delay in the presentation of breast cancer. One hundred and eighty-five cancer patients attending a breast unit were interviewed 2 months after diagnosis. The main outcome measures were patient delay in prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgess, C. C., Ramirez, A. J., Richards, M. A., Love, S. B.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150175/
https://www.ncbi.nlm.nih.gov/pubmed/9579844
_version_ 1782144590121271296
author Burgess, C. C.
Ramirez, A. J.
Richards, M. A.
Love, S. B.
author_facet Burgess, C. C.
Ramirez, A. J.
Richards, M. A.
Love, S. B.
author_sort Burgess, C. C.
collection PubMed
description This study aimed to examine the extent and determinants of patient and general practitioner delay in the presentation of breast cancer. One hundred and eighty-five cancer patients attending a breast unit were interviewed 2 months after diagnosis. The main outcome measures were patient delay in presentation to the general practitioner and non-referral by the general practitioner to hospital after the patient's first visit. Nineteen per cent of patients delayed > or = 12 weeks. Patient delay was related to clinical tumour size > or = 4 cm (P = 0.0002) and with a higher incidence of locally advanced and metastatic disease (P = 0.01). A number of factors predicted patient delay: initial breast symptom(s) that did not include a lump (OR 4.5, P = 0.003), not disclosing discovery of the breast symptom immediately to someone else (OR 6.0, P < 0.001), seeking help only after being prompted by others (OR 4.4, P = 0.007) and presenting to the general practitioner with a non-breast problem (OR 3.5, P = 0.03). Eighty-three per cent of patients were referred to hospital directly after their first general practitioner visit. Presenting to the GP with a breast symptom that did not include a lump independently predicted general practitioner delay (OR 3.6, P = 0.002). In view of the increasing evidence that delay adversely affects survival, a large multicentre study is now warranted to confirm these findings that may have implications for public and medical education.
format Text
id pubmed-2150175
institution National Center for Biotechnology Information
language English
publishDate 1998
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-21501752009-09-10 Who and what influences delayed presentation in breast cancer? Burgess, C. C. Ramirez, A. J. Richards, M. A. Love, S. B. Br J Cancer Research Article This study aimed to examine the extent and determinants of patient and general practitioner delay in the presentation of breast cancer. One hundred and eighty-five cancer patients attending a breast unit were interviewed 2 months after diagnosis. The main outcome measures were patient delay in presentation to the general practitioner and non-referral by the general practitioner to hospital after the patient's first visit. Nineteen per cent of patients delayed > or = 12 weeks. Patient delay was related to clinical tumour size > or = 4 cm (P = 0.0002) and with a higher incidence of locally advanced and metastatic disease (P = 0.01). A number of factors predicted patient delay: initial breast symptom(s) that did not include a lump (OR 4.5, P = 0.003), not disclosing discovery of the breast symptom immediately to someone else (OR 6.0, P < 0.001), seeking help only after being prompted by others (OR 4.4, P = 0.007) and presenting to the general practitioner with a non-breast problem (OR 3.5, P = 0.03). Eighty-three per cent of patients were referred to hospital directly after their first general practitioner visit. Presenting to the GP with a breast symptom that did not include a lump independently predicted general practitioner delay (OR 3.6, P = 0.002). In view of the increasing evidence that delay adversely affects survival, a large multicentre study is now warranted to confirm these findings that may have implications for public and medical education. Nature Publishing Group 1998-04 /pmc/articles/PMC2150175/ /pubmed/9579844 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Burgess, C. C.
Ramirez, A. J.
Richards, M. A.
Love, S. B.
Who and what influences delayed presentation in breast cancer?
title Who and what influences delayed presentation in breast cancer?
title_full Who and what influences delayed presentation in breast cancer?
title_fullStr Who and what influences delayed presentation in breast cancer?
title_full_unstemmed Who and what influences delayed presentation in breast cancer?
title_short Who and what influences delayed presentation in breast cancer?
title_sort who and what influences delayed presentation in breast cancer?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150175/
https://www.ncbi.nlm.nih.gov/pubmed/9579844
work_keys_str_mv AT burgesscc whoandwhatinfluencesdelayedpresentationinbreastcancer
AT ramirezaj whoandwhatinfluencesdelayedpresentationinbreastcancer
AT richardsma whoandwhatinfluencesdelayedpresentationinbreastcancer
AT lovesb whoandwhatinfluencesdelayedpresentationinbreastcancer